Extracellular Vesicles as Biomarkers of Pregnancy Complications
International Journal of Molecular Sciences · 06.11.2024 · 25 (22) · 11944
DOI: 10.3390/ijms252211944 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.11.2024. Verfasst von Anastasiia K Popova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, D.O. Ott Research Institute for Obstetrics, Gynecology, and Reproduction, St. Petersburg 199034, Russia. Hauptthemen laut MEDLINE: Extracellular Vesicles, Biomarkers, Pregnancy Complications, MicroRNAs. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are double-membrane vesicles that facilitate intercellular communication and play a pivotal role in both physiological and pathological processes. A substantial body of evidence suggests that EVs play a role in the pathogenesis of various pregnancy complications. Because EVs can be detected in the peripheral blood, they are potential biomarkers for the early diagnosis of pregnancy complications and foetal developmental disorders. The majority of studies have demonstrated a correlation between alterations in the concentration of EVs and changes in their contents and the occurrence of pregnancy complications. Despite the current limitations in establishing a clear link between these findings and the pathogenesis of the disease, as well as the lack of sufficient evidence to support their use in clinical practice, it is noteworthy to highlight the potential role of specific miRNAs carried by EVs in the development of pregnancy complications. These include miR-210 and miR-136-5p for pre-eclampsia and gestational diabetes mellitus, miR-155, miR-26b-5p, miR-181a-5p, miR-495 and miR-374c for pre-eclampsia and preterm birth. The following miRNAs have been identified as potential biomarkers for preterm birth and gestational diabetes mellitus: miR-197-3p and miR-520h, miR-1323, miR-342-3p, miR-132-3p, miR-182-3p, miR-517-3p, miR-222-3p, miR-16-5p and miR-126-3p. Additionally, miR-127-3p has been linked to foetal growth restriction and preterm birth. Nevertheless, it would be premature to propose that EVs can be employed as biomarkers for pregnancy complications. Further research and the accumulation of results obtained using the methods proposed in the MISEV2023 guidelines will enable a definitive conclusion to be reached.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genomic Medicine, D.O. Ott Research Institute for Obstetrics, Gynecology, and Reproduction, St. Petersburg 199034, Russia.
- Department of Genetics and Biotechnology, St. Petersburg State University, St. Petersburg 199034, Russia.
ORCID-Profile: Anastasiia K Popova, Olga V Pachuliia, Andrey S Glotov
Förderung
- Russian Science Foundation
Zitieren
APA
Popova, A. K., Vashukova, E. S., Illarionov, R. A., Maltseva, A. R., Pachuliia, O. V., Postnikova, T. B., & Glotov, A. S. (2024). Extracellular Vesicles as Biomarkers of Pregnancy Complications. International Journal of Molecular Sciences, 25(22), 11944. https://doi.org/10.3390/ijms252211944
Vancouver
Popova AK, Vashukova ES, Illarionov RA, Maltseva AR, Pachuliia OV, Postnikova TB, et al. Extracellular Vesicles as Biomarkers of Pregnancy Complications. International Journal of Molecular Sciences. 2024;25(22):11944. doi:10.3390/ijms252211944
BibTeX
@article{Popova2024,
author = {Popova, Anastasiia K and Vashukova, Elena S and Illarionov, Roman A and Maltseva, Anastasia R and Pachuliia, Olga V and Postnikova, Tatiana B and Glotov, Andrey S},
title = {Extracellular Vesicles as Biomarkers of Pregnancy Complications},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {22},
pages = {11944},
doi = {10.3390/ijms252211944}
}
EUVIMED